T-large granular lymphocyte leukemia: current molecular concepts

References

• Lamy T, Loughran TP Jr. Clinical features of large granular lymphocyte leukemia. Semin Hematol 2003;40(3):185–195.
   PubMed Web of Science ®Google Scholar
• Lamy T, Loughran, TP Jr. Current concepts: Large granular lymphocyte leukemia. Blood Rev 1999;13(4):230–240.
   PubMed Web of Science ®Google Scholar
• Loughran TP Jr, Starkebaum G. Large granular lymphocyte leukemia. Report of 38 cases and review of the literature. Medicine (Baltimore) 1987;66(5):397–405.
   PubMed Web of Science ®Google Scholar
• Rose MG, Berliner N. T-cell large granular lymphocyte leukemia and related disorders. Oncologist 2004;9(3): 247–258.
   PubMed Web of Science ®Google Scholar
• Greer JP, Kinney MC, Loughran, TP Jr. T cell and NK cell lymphoproliferative disorders. Hematology (Am Soc Hema-tol Educ Program) Jan 2001;259–281.
   Google Scholar
• Loughran TP Jr. Clonal diseases of large granular lympho-cytes. Blood 1993;82 (1):1–14.
   PubMed Web of Science ®Google Scholar
• Loughran TP Jr, Starkebaum G, Aprile JA. Rearrangement and expression of T-cell receptor genes in large granular lymphocyte leukemia. Blood 1988;71(3):822–824.
   PubMed Web of Science ®Google Scholar
• Dhodapkar MV, Li CY, Lust JA, Tefferi A, Phyliky RL. Clinical spectrum of clonal proliferations of T-large granular lymphocytes: A T-cell clonopathy of undetermined signifi-cance? Blood 1994;84(5):1620–1627.
   PubMed Web of Science ®Google Scholar
• Kwong YL, Wong KF. Association of pure red cell aplasia with T large granular lymphocyte leukaemia. J Chin Pathol 1998;51(9):672–675.
   PubMed Web of Science ®Google Scholar
• Go RS, Li CY, Tefferi A, Phyliky RL. Acquired pure red cell aplasia associated with lymphoproliferative disease of granular T lymphocytes. Blood 2001;98(2):483–485.
   PubMed Web of Science ®Google Scholar
• Loughran, TP Jr, Kadin ME, Starkebaum G, Abkowitz JL, Clark EA, Disteche C, Lum LG, Slichter SJ. Leukemia of large granular lymphocytes: Association with clonal chromo-somal abnormalities and autoimmune neutropenia, throm-bocytopenia, and hemolytic anemia. Ann Intern Med 1985;102(2):169–175.
   PubMed Web of Science ®Google Scholar
• Akashi K, Shibuya T, Taniguchi S, Hayashi S, Iwasaki H, Teshima T, Takamatsu Y, Gondo H, Okamura T, Harada M, Niho Y. Multiple autoimmune haemopoietic disorders and insidious clonal proliferation of large granular lymphocytes. Br J Haematol 1999;107 (3):670–673.
   PubMed Web of Science ®Google Scholar
• Osuji N, Matutes E, Dearden C, Catovsky D. Pregnancy improves neutropenia in T-cell large granular lymphocyte leukaemia. Br J Haematol 2005;128(5):645–648.
   PubMed Web of Science ®Google Scholar
• Lima M, Almeida J, Santos AH, dos Anjos TM, Alguero MC, Queiros ML, Balanzategui A, Justica B, Gonzalez M, San Miguel JF, Orfao A. Immunophenotypic analysis of the TCR-Vbeta repertoire in 98 persistent expansions of CD3(+)/TCR-alphabeta(+) large granular lymphocytes: Utility in assessing clonality and insights into the pathogen-esis of the disease. Am J Pathol 2001;159(5):1861–1868.
   PubMed Web of Science ®Google Scholar
• Semenzato G, Zambello R, Starkebaum G, Oshimi K, Loughran TP Jr. The lymphoproliferative disease of granular lymphocytes: Updated criteria for diagnosis. Blood 1997;89(1):256–260.
   PubMed Web of Science ®Google Scholar
• Melenhorst JJ, Eniafe R, Follmann D, Molldrem J, Kirby M, El OF, Barrett AJ. T-cell large granular lymphocyte leukemia is characterized by massive TCRBV-restricted clonal CD8 expansion and a generalized overexpression of the effector cell marker CD57. Hematol J 2003;4(1):18–25.
   PubMedGoogle Scholar
• Herling M, Khoury JD, Washington LT, Duvic M, Keating MJ, Jones D. A systematic approach to diagnosis of mature T-cell leukemias reveals heterogeneity among WHO cat-egories. Blood 2004;104(2):328–335.
   PubMed Web of Science ®Google Scholar
• Morice WG, Kurtin PJ, Leibson PJ, Tefferi A, Hanson CA. Demonstration of aberrant T-cell and natural killer-cell antigen expression in all cases of granular lymphocytic leukaemia. Br J Haematol 2003;120(6):1026–1036.
   PubMed Web of Science ®Google Scholar
• Dang NH, Aytac U, Sato K, O’Brien S, Melenhorst J, Morimoto C, Barrett AJ, Molldrem H. T-large granular lymphocyte lymphoproliferative disorder: Expression of CD26 as a marker of clinically aggressive disease and characterization of marrow inhibition. Br J Haematol 2003;121 (6): 857–865.
   PubMed Web of Science ®Google Scholar
• Lundell R, Hartung L, Hill S, Perkins SL, Bahler DW. T-cell large granular lymphocyte leukemias have multiple pheno-typic abnormalities involving pan-T-cell antigens and receptors for MHC molecules. Am J Clin Pathol 2005;124 (6):937–946.
   PubMed Web of Science ®Google Scholar
• Bigouret V, Hoffmann T, Arlettaz L, Villard J, Colonna M, Ticheli A, Gratwohl A, Samfi K, Chapuis B, Rufer N, Roosnek E. Monoclonal T-cell expansions in asymptomatic individuals and in patients with large granular leukemia consist of cytotoxic effector T cells expressing the activating CD94:NKG2C/E and NKD2D killer cell receptors. Blood 2003;101 (8):3198–3204 .
   PubMed Web of Science ®Google Scholar
• Hoffmann T, LG, Colonna M, Wodnar-Filipowicz A, Passweg J, Favre G, Gratwohl A, Tichelli A. Natural killer-type receptors for HLA class I antigens are clonally expressed in lymphoproliferative disorders of natural killer and T-cell type. Br J Haematol 2000;110(3):525–536.
   PubMed Web of Science ®Google Scholar
• Ryan DK, Alexander HD, Morris TC. Routine diagnosis of large granular lymphocytic leukaemia by Southern blot and polymerase chain reaction analysis of clonal T cell receptor gene rearrangement. Mol Pathol 1997;50(2):77–81.
   PubMedGoogle Scholar
• Berliner N, Duby AD, Linch DC, Murre C, Quertermous T, Knott LJ, Azin T, Newland AC, Lewis DL, Galvin MC. T cell receptor gene rearrangements define a monoclonal T cell proliferation in patients with T cell lymphocytosis and cytopenia. Blood 1986;67 (4): 914–918.
   PubMed Web of Science ®Google Scholar
• Brenchley JM, Karandikar NJ, Betts MR, Ambrozak DR, Hill BJ, Crotty LE, Casazza JP, Kuruppu J, Migueles SA, Connors M, Roederer M, Douek DC, Koup RA. Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ T cells. Blood 2003;101(7):2711–2720.
   PubMed Web of Science ®Google Scholar
• Posnett DN, Sinha R, Kabak S, Russo C. Clonal populations of T cells in normal elderly humans: The T cell equivalent to "benign monoclonal gammapathy". J Exp Med 1994; 179(2):609–618.
   PubMed Web of Science ®Google Scholar
• Lamy T, Loughran TP. Large granular lymphocyte leukemia. Cancer Control 1998;5(1):25–33.
   PubMedGoogle Scholar
• Molad Y, Okon E, Stark P, Prokocimer M. Sjogren’s syndrome associated T cell large granular lymphocyte leukemia: A possible common etiopathogenesis. J Rheumatol 2001;28(11) :2551–2552.
   PubMed Web of Science ®Google Scholar
• Marlton P, Taylor K, Elliott S, McCormack J. Monoclonal large granular lymphocyte proliferation in SLE with HTLV-I seroreactivity. Aust N Z J Med 1992;22(1):54–55.
   PubMedGoogle Scholar
• Lima M, Goncalves C, Marques L, Martin MC, Teixeira MA, Queiros ML, Santos AH, Balanzategui A, Garcia-Sanz R, Pinto-Ribeiro AC, Justica B, Orfao A. Association of CD4+/CD56+/CD57+/CD8+ (dim) large granular lym-phocytic leukemia, splenic B-cell lymphoma with circulating villous lymphocytes, and idiopathic erythrocytosis. Ann Hematol 2001;80(11):685–690.
   PubMed Web of Science ®Google Scholar
• Charlanne H, Lambert M, Hachulla E, Launay D, Queyrel V, Hatron PY, Devulder B, Muller JY. Large granular lymphocyte leukaemia associated with systemic sclerosis. Rheumatology (Oxford) 2004;43(9): 1197–1198.
   PubMed Web of Science ®Google Scholar
• Valmori D, Ayyoub M, Hesdorffer CS, Keilholz U, Scheibenbogen C. A monoclonal melanoma-specific T-cell population phenotypically indistinguishable from CD3+ LGL-leukemia. Blood 2003;101(11):4643–4644.
   PubMed Web of Science ®Google Scholar
• Kondo H, Watanabe J, Iwasaki H. T-large granular lymphocyte leukemia accompanied by an increase of natural killer cells (CD3−) and associated with ulcerative colitis and autoimmune hepatitis. Leuk Lymphoma 2001; 41(1–2):207–212.
   PubMed Web of Science ®Google Scholar
• Kaplanski G, Seidel-Farnarier C, Durand JM, Harle JR, Horchowski N, Fossat C, Bongrand P, Kaplanski S. "NK-ike" T cytotoxicity against B lymphocytes in a hypogammaglobulinemic patient. Immunol Invest 1992;21(7):601–612.
   PubMed Web of Science ®Google Scholar
• Starkebaum G, Loughran TP Jr. Gaur LK, Davis P, Nepom BS. Immunogenetic similarities between patients with Felty’s syndrome and those with clonal expansions of large granular lymphocytes in rheumatoid arthritis. Arthritis Rheum 1997;40(4):624–626.
   PubMed Web of Science ®Google Scholar
• Berliner N, Horwitz M, Loughran TP Jr. Congenital and acquired neutropenia. Hematology (Am Soc Hematol Educ Program) 2004;63–79.
   Google Scholar
• Bowman SJ, Bhavnani M, Geddes GC, Corrigall V, Boylston AW, Panayi GS, Lanchbury JS. Large granular lymphocyte expansions in patients with Felty’s syndrome: Analysis using anti-T cell receptor V beta-specific monoclonal antibodies. Chin Exp Immunol 1995;101(1):18–24.
   PubMed Web of Science ®Google Scholar
• Bowman SJ, Hall MA, Panayi GS, Lanchbury JS. T cell receptor alpha-chain and beta-chain junctional region homology in clonal CD3±, CD8+ T lymphocyte expansions in Felty’s syndrome. Arthritis Rheum 1997;40(4):615–623.
   PubMed Web of Science ®Google Scholar
• Handgretinger R, Geiselhart A, Moris A, Grau R, Teuffel O, Bethge W, Kanz L, Fisch P. Pure red-cell aplasia associated with clonal expansion of granular lymphocytes expressing killer-cell inhibitory receptors. N Engl J Med 1999; 340(4):278–284.
   PubMed Web of Science ®Google Scholar
• Fogarty PF, Stetler-Stevenson M, Pereira A, Dunbar CE. Large granular lymphocytic proliferation-associated cyclic thrombocytopenia. Am J Hematol 2005;79(4):334–336.
   PubMed Web of Science ®Google Scholar
• Risitano AM, Maciejewski JP, Muranski P, Wlodarski M, O’keefe C, Sloand EM, Young NS. Large granular lymphocyte (LGL)-like clonal expansions in paroxysmal nocturnal hemoglobinuria (PNH) patients. Leukemia 2005;19(2):217–222.
   PubMed Web of Science ®Google Scholar
• Karadimitris A, Li K, Notaro R, Araten DJ, Nafa K, Thertulien R, Ladanyi M, Stevens AE, Rosenfeld CS, Roberts IA, Luzzatto L. Association of clonal T-cell large granular lymphocyte disease and paroxysmal nocturnal haemoglobinuria (PNH): Further evidence for a athogenetic link between T cells, aplastic anaemia and PNH. Br J Haematol 2001;115(4):1010–1014.
   PubMed Web of Science ®Google Scholar
• Go RS, Tefferi A, Li CY, Lust JA, Phyliky RL. Lymphoproliferative disease of granular T lymphocytes presenting as aplastic anemia. Blood 2000;96(10):3644–3646.
   PubMed Web of Science ®Google Scholar
• Saunthararajah Y, Molldrem JL, Rivera M, Williams A, Stetler-Stevenson M, Sorbara L, Young NS, Barrett JA. Coincident myelodysplastic syndrome and T-cell large granular lymphocytic disease: Clinical and pathophysiological features. Br J Haematol 2001;112(1):195–200.
   PubMed Web of Science ®Google Scholar
• Kochenderfer JN, Kobayashi S, Wieder ED, Su C, Molldrem JJ. Loss of T-lymphocyte clonal dominance in patients with T-large granular lymphocyte proliferations associated with clonal B cell lymphoproliferative disorders: Report of eight cases. Leukemia 2002;16(10):2167–2169.
   PubMed Web of Science ®Google Scholar
• Papadaki T, Stamatopoulos K, Kosmas C, Paterakis G, Kapsimali V, Kokkini G, Economopoulos T, Stefanoudaki-Sofianatou K, Marinakis T, Gardikas E, Kalmantis T. Clonal T-large granular lymphocyte proliferations associated with clonal B cell lymphoproliferative disorders: Report of eight cases. Leukemia 2002;16(10):2167–2169.
   PubMed Web of Science ®Google Scholar
• Lesesve JF, Feugier P, Lamy T, Bene MC, Gregoire MJ, Lenormand B, Loughran T. Association of B-chronic lymphocytic leukaemia and T-large granular lymphocyte leukaemia. Chin Lab Haematol 2000;22(2):121–122.
   PubMedGoogle Scholar
• Kingreen D, Dalal BI, Heyman M, Phillips GL, Horsman D, Kidd P, Loughran TP Jr. Lymphocytosis of large granular lymphocytes in patients with Hodgkin’s disease. Am J Hematol 1995;50(4):234–236.
   PubMed Web of Science ®Google Scholar
• Callan MF, Steven N, Krausa P, Wilson JD, Moss PA, Gillespie GM, Bell JI, Rickinson AB, McMichael AJ. Large clonal expansions of CD8+ T cells in acute infectious mononucleosis. Nat Med 1996;2(8):906–911.
   PubMed Web of Science ®Google Scholar
• Pantaleo G, Demarest JF, Soudeyns H, Graziosi C, Denis F, Adelsberger JW, Borrow P, Saag MS, Shaw GM, Sekaly RP. Major expansion of CD8+ T cells with a predominant V beta usage during the primary immune response to HIV. Nature 1994;370(6489):463–467.
   PubMed Web of Science ®Google Scholar
• Mongkolsapaya J, Jaye A, Callan MF, Magnusen AF, McMichael AJ, Whittle HC. Antigen-specific expansion of cytotoxic T lymphocytes in acute measles virus infection. J Virol 1999;73(1):67–71.
   PubMed Web of Science ®Google Scholar
• Kronenberg A, Seebach JD, Bossart W, Weber R. Polyclonal proliferation of large granular lymphocytes during cytome-galovirus primary infection in a human immunodeficiency virus-infected patient receiving antiretroviral therapy. Chin Infect Dis 2001;33(5):E34—E36.
   PubMed Web of Science ®Google Scholar
• Au WY, Lam CC, Lie AK, Pang A, Kwong YL. T-cell large granular lymphocyte leukemia of donor origin after allogeneic bone marrow transplantation. Am J Chin Pathol 2003; 120(4):626–630.
   PubMed Web of Science ®Google Scholar
• Mohty M, Faucher C, Gaugler B, Vey N, Sainty D, Arnoulet C, Mozziconacci MJ, Isnardon D, Gastaut JA, Maraninchi D, Olive D, Blaise D. Large granular lymphocytes (LGL) following non-myeloablative allogeneic bone marrow trans-plantation: A case report. Bone Marrow Transplant 2001;28(12):1157–1160.
   PubMed Web of Science ®Google Scholar
• Mohty M, Faucher C, Vey N, Chabannon C, Sainty D, Arnoulet C, Gaugler B, Gastaut JA, Maraninchi D, Olive D, Blaise D. Features of large granular lymphocytes (LGL) expansion following allogeneic stem cell transplantation: A long-term analysis. Leukemia 2002;16 (10): 2129—2133.
   PubMed Web of Science ®Google Scholar
• Chang H, Kamel-Reid S, Hussain N, Lipton J, Messner HA. T-cell large granular lymphocytic leukemia of donor origin occurring after allogeneic bone marrow transplantation for B-cell lymphoproliferative disorders. Am J Chin Pathol 2005; 123(2) :196–199.
   PubMed Web of Science ®Google Scholar
• Feher O, Barilla D, Locker J, Oliveri D, Melhem M, Winkelstein A. T-cell large granular lymphocytic leukemia following orthotopic liver transplantation. Am J Hematol 1995;49 (3):216—220.
   PubMed Web of Science ®Google Scholar
• Gentile TC, Hadlock KG, Uner AH, Delal B, Squiers E, Crowley S, Woodman RC, Foung SK, Poiesz BJ, Loughran TP Jr. Large granular lymphocyte leukaemia occurring after renal transplantation. Br J Haematol 1998;101 (3):507—512.
   PubMed Web of Science ®Google Scholar
• Messmer BT, Albesiano E, Efremov DG, Ghiotto F, Allen SL, Kolitz J, Foa R, Damle RN, Fais F, Messmer D, Rai KR, Ferrarini M, Chiorazzi N. Multiple distinct sets of stereo-typed antigen receptors indicate a role for antigen in promoting chronic lymphocytic leukemia. J Exp Med 2004; 200(4):519–525.
   PubMed Web of Science ®Google Scholar
• Herve M, Xu K, Ng YS, Wardemann H, Albesiano E, Messmer BT, Chiorazzi N, Meffre E. Unmutated and mutated chronic lymphocytic leukemias derive from self-reactive B cell precursors despite expressing different antibody reactivity. J Chin Invest 2005;115 (6):1636–1643.
   PubMed Web of Science ®Google Scholar
• Perzova R, Loughran TP Jr. Constitutive expression of Fas ligand in large granular lymphocyte leukaemia. Br J Haematol 1997;97 (1):123—126.
   PubMed Web of Science ®Google Scholar
• Oshimi K, Shinkai Y, Okumura K, Oshimi Y, Mizoguchi H. Perform gene expression in granular lymphocyte proliferative disorders. Blood 1990;75(3):704–708.
   PubMed Web of Science ®Google Scholar
• Kothapalli R, Bailey RD, Kusmartseva I, Mane S, Epling-Burnette PK, Loughran TP Jr. Constitutive expression of cytotoxic proteases and down-regulation of protease inhibi-tors in LGL leukemia. Int J Oncol 2003;22(1):33–39.
   PubMed Web of Science ®Google Scholar
• Mollet L, Fautrel B, Leblond V, Bergeron F, Merle-Beral H, Baumelou E, Hubert P, Debre P, Autran B. Leukemic CD3+ LGL share functional properties with their CD8+ CD57+ cell counterpart expanded after BMT. Leukemia 1999; 13(2):230–240.
   PubMed Web of Science ®Google Scholar
• Coakley G, Iqbal M, Brooks D, Panayi GS, Lanchbury JS. CD8+, CD57+ T cells from healthy elderly subjects suppress neutrophil development in vitro: Implications for the neutropenia of Felty’s and large granular lymphocyte syndromes. Arthritis Rheum 2000;43(4):834–843.
   PubMed Web of Science ®Google Scholar
• Aprile JA, Russo M, Pepe MS, Loughran TP Jr. Activation signals leading to proliferation of normal and leukemic C D3 +largegranularlymphocytes.Blood1991;78 (5): 1282–1285.
   PubMed Web of Science ®Google Scholar
• Melenhorst JJ, Sorbara L, Kirby M, Hensel NF, Barrett AJ. Large granular lymphocyte leukaemia is characterized by a clonal T-cell receptor rearrangement in both memory and effector CD8(+) lymphocyte populations. Br J Haematol 2001;112(1):189–194.
   PubMed Web of Science ®Google Scholar
• Nagata S. Apoptosis by death factor. Cell 1997;88(3): 355–365.
   PubMed Web of Science ®Google Scholar
• Suda T, Takahashi T, Golstein P, Nagata S. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 1993;75(6): 1169–1178.
   PubMed Web of Science ®Google Scholar
• Suda T, Okazaki T, Naito Y, Yokota T, Arai N, Ozaki S, Nakao K, Nagata S. Expression of the Fas ligand in cells of T cell lineage. J Immunol 1995;154(8):3806–3813.
   PubMed Web of Science ®Google Scholar
• Suda T, Hashimoto H, Tanaka M, Ochi T, Nagata S. Membrane Fas ligand kills human peripheral blood T lymphocytes, and soluble Fas ligand blocks the killing. J Exp Med 1997;186(12):2045–2050.
   PubMed Web of Science ®Google Scholar
• Lamy T, Liu JH, Landowski TH, Dalton WS, Loughran TP Jr. Dysregulation of CD95/CD95 ligand-apoptotic pathway in CD3(+) large granular lymphocyte leukemia. Blood 1998;92 (12):4771–4777.
   PubMed Web of Science ®Google Scholar
• Liu JH, Wei S, Lamy T, Epling-Burnette PK, Starkebaum G, Djeu JY, Loughran TP. Chronic neutropenia-mediated by Fas ligand. Blood 2000;95(10):3219–3222.
   PubMed Web of Science ®Google Scholar
• Yu CL, Meyer DJ, Campbell GS, Lamer AC, Carter-Su C, Schwartz J, Jove R. Enhanced DNA-binding activity of a Stat3-related protein in cells transformed by the Src oncoprotein. Science 1995;269 (5220): 81–83.
   PubMed Web of Science ®Google Scholar
• Epling-Burnette PK, Liu JH, Catlett-Falcone R, Turkson J, Oshiro M, Kothapalli R, Li Y, Wang JM, Yang-Yen HF, Karras J, Jove R, Loughran TP Jr. Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mc-1 expression. J Chin Invest 2001;107 (3) :351–362.
   Web of Science ®Google Scholar
• Epling-Burnette PK, Loughran TP Jr.. Survival signals in leukemic large granular lymphocytes. Semin Hematol 2003;40 (3): 213–220.
   Google Scholar
• Schade AE, Powers H, Wlodarski MW, Maciejewski JP. Phosphatidylinosito1-3-phosphate kinase pathway activation protects leukemic large granular lymphocytes from under-going homeostatic apoptosis. Blood Feb 2006.
   Google Scholar
• Epling-Burnette PK, Bai F, Wei S, Chaurasia P, Painter JS, Olashaw N, Hamilton A, Sebti S, Djeu JY, Loughran TP. ERK couples chronic survival of NK cells to constitutively activated Ras in lymphoproliferative disease of granular lymphocytes (LDGL). Oncogene 2004;23(57):9220–9229.
   PubMed Web of Science ®Google Scholar
• Loughran TP Jr, Hadlock KG, Perzova R, Gentile TC, Yang Q, Foung SK, Poiesz Bj. Epitope mapping of HTLV envelope seroreactivity in LGL leukaemia. Br J Haematol 1998; 101(2):318–324.
   PubMed Web of Science ®Google Scholar
• Tagawa S, Mizuki M, Onoi U, Nakamura Y, Nozima J, Yoshida H, Kondo K, Mukai T, Yamanishi K, Kitani T. Transformation of large granular lymphocytic leukemia during the course of a reactivated human herpesvirus-6 infection. Leukemia 1992;6(5):465–469.
   PubMed Web of Science ®Google Scholar
• Loughran TP Jr, Coyle T, Sherman MP, Starkebaum G, Ehrlich GD, Ruscetti FW, Poiesz BJ. Detection of human T-cell leukemia/lymphoma virus, type II, in a patient with large granular lymphocyte leukemia. Blood 1992;80(5): 1116–1119.
   PubMed Web of Science ®Google Scholar
• Hart DN, Baker BW, Inglis MJ, Nimmo JC, Starling GC, Deacon E, Rowe M, Beard ME. Epstein-Barr viral DNA in acute large granular lymphocyte (natural killer) leukemic cells. Blood 1992;79(8):2116–2123.
   PubMed Web of Science ®Google Scholar
• Loughran TP Jr, Zambello R, Ashley R, Guderian J, Pellenz M, Semenzato G, Starkebaum G. Failure to detect Epstein-Barr virus DNA in peripheral blood mononuclear cells of most patients with large granular lymphocyte leukemia. Blood 1993;81(10):2723–2727.
   PubMed Web of Science ®Google Scholar
• Takahashi A, Day NK, Luangwedchakarn V, Good RA, Haraguchi S. A retroviral-derived immunosuppressive pep-tide activates mitogen-activated protein kinases. J Immunol 2001;166(11):6771–6775.
   PubMed Web of Science ®Google Scholar
• Swa S, Wright H, Thomson J, Reid H, Haig D. Constitutive activation of Lck and Fyn tyrosine kinases in large granular lymphocytes infected with the gamma-herpesvirus agents of malignant catarrhal fever. Immu-nology 2001;102(1):44–52.
   Google Scholar
• Davis MM, Bjorkman PJ. T-cell antigen receptor genes and T-cell recognition. Nature 1988;334 (6181):395–402.
   PubMed Web of Science ®Google Scholar
• Landau NR, Schatz DG, Rosa M, Baltimore D. Increased frequency of N-region insertion in a murine pre-B-cell line infected with a terminal deoxynucleotidyl transferase retro-viral expression vector. Mol Cell Biol 1987;7(9): 3237–3243.
   PubMed Web of Science ®Google Scholar
• Arstila TP, Casrouge A, Baron V, Even J, Kanellopoulos J, Kourilsky P. Diversity of human alpha beta T cell receptors. Science 2000;288(5469):1135.
   PubMedGoogle Scholar
• Macintyre EA, Delabesse E. Molecular approaches to the diagnosis and evaluation of lymphoid malignancies. Semin Hematol 1999;36(4):373–389.
   PubMed Web of Science ®Google Scholar
• Oettinger MA, Schatz DG, Gorka C, Baltimore D. RAG-1 and RAG-2, adjacent genes that synergistically activate V(D)J recombination. Science 1990;248(4962):1517–1523.
   PubMed Web of Science ®Google Scholar
• Alt FW, Oltz EM, Young F, Gorman J, Taccioli G, Chen J. VDJ recombination. Immunol Today 1992;13 (8):306–314.
   PubMedGoogle Scholar
• Nadel B, Feeney AJ. Nucleotide deletion and P addition in V(D)J recombination: A determinant role of the coding-end sequence. Mol Cell Biol 1997;17(7):3768–3778.
   PubMed Web of Science ®Google Scholar
• Janeway CPTMWMS. The immune system in health and disease. 6th ed. New York: Garland Publishing; 2005.
   Google Scholar
• Dik WA, Pike-Overzet K, Weerkamp F, de RD, de Haas EF, Baert MR, van der SP, Koster EE, Reinders MJ, van Dongen JJ, Langerak AW, Staal FJ. New insights on human T cell development by quantitative T cell receptor gene rearrange-ment studies and gene expression profiling. J Exp Med 2005;201(11):1715–1723.
   PubMed Web of Science ®Google Scholar
• Plasilova M, Risitano A, Maciejewski JP. Application of the molecular analysis of the T-cell receptor repertoire in the study of immune-mediated hematologic diseases. Hema-tology 2003;8(3):173–181.
   PubMedGoogle Scholar
• Charmley P, Concannon P. PCR-based genotyping and haplotype analysis of human TCRBV gene segment poly-morphisms. Immunogenetics 1995;42(4):254–261.
   PubMed Web of Science ®Google Scholar
• McCarthy KP, Sloane JP, Kabarowski JH, Matutes E, Wiedemann LM. A simplified method of detection of clonal rearrangements of the T-cell receptor-gamma chain gene. Diagn Mol Pathol 1992;1 (3): 173— 179 .
   PubMedGoogle Scholar
• McCarthy KP, Sloane JP, Kabarowski JH, Matutes E, Wiedemann LM. The rapid detection of clonal T-cell proliferations in patients with lymphoid disorders. Am J Pathol 1991;138(4): 821— 828.
   PubMed Web of Science ®Google Scholar
• Droese J, Langerak AW, Groenen PJ, Bruggemann M, Neumann P, Wolvers-Tettero IL, van Altena MC, Kneba M, van Dongen JJ. Validation of BIOMED-2 multiplex PCR tubes for detection of TCRB gene rearrangements in T-cell malignancies. Leukemia 2004;18(9) :1531–1538.
   PubMed Web of Science ®Google Scholar
• Silins SL, Cross SM, Krauer KG, Moss DJ, Schmidt CW, Misko IS. A functional link for major TCR expansions in healthy adults caused by persistent Epstein-Barr virus infection. J Chin Invest 1998;102(8):1551–1558.
   PubMed Web of Science ®Google Scholar
• Risitano AM, Maciejewski JP, Green S, Plasilova M, Zeng W, Young NS. In-vivo dominant immune responses in aplastic anaemia: Molecular tracking of putatively pathogenetic T-cell clones by TCR beta-CDR3 sequencing. Lancet 2004; 364(9431):355–364.
   PubMed Web of Science ®Google Scholar
• Gorski J, Yassai M, Zhu X, Kissela B, Kissella B, Keever C, Flomenberg N. Circulating T cell repertoire complexity in normal individuals and bone marrow recipients analyzed by CDR3 size spectratyping. Correlation with immune status. J Immunol 1994;152(10):5109–5119.
   PubMed Web of Science ®Google Scholar
• Pannetier C, Even J, Kourilsky P. T-cell repertoire diversity and clonal expansions in normal and clinical samples. Immunol Today 1995;16(4) :176–181.
   PubMedGoogle Scholar
• Borg NA, Ely LK, Beddoe T, Macdonald WA, Reid HH, Clements CS, Purcell AW, Kjer-Nielsen L, Miles JJ, Burrows SR, McCluskey J, Rossjohn J. The CDR3 regions of an immunodominant T cell receptor dictate the ’energetic landscape’ of peptide-MHC recognition. Nat Immunol 2005;6 (2) :171–180.
   PubMed Web of Science ®Google Scholar
• Stewart-Jones GB, McMichael AJ, Bell JI, Stuart DI, Jones EY. A structural basis for immunodominant human T cell receptor recognition. Nat Immunol 2003;4(7):657–663.
   PubMed Web of Science ®Google Scholar
• Kjer-Nielsen L, Clements CS, Purcell AW, Brooks AG, Whisstock JC, Burrows SR, McCluskey J, Rossjohn J. A structural basis for the selection of dominant alphabeta T cell receptors in antiviral immunity. Immunity 2003;18(1): 53–64.
   PubMed Web of Science ®Google Scholar
• Padovan E, Casorati G, Dellabona P, Meyer S, Brockhaus M, Lanzavecchia A. Expression of two T cell receptor alpha chains: Dual receptor T cells. Science 1993;262(5132): 422–424.
   PubMed Web of Science ®Google Scholar
• Plasilova M, Risitano A, Maciejewski JP. Application of the molecular analysis of the T cell receptor repertoire in the study of immune-mediated hematologic disease. Hematol J 2003;8 (3) :173–181.
   Google Scholar
• Hodges E, Krishna MT, Pickard C, Smith JL. Diagnostic role of tests for T cell receptor (TCR) genes. J Chin Pathol 2003;56(1):1–11.
   PubMed Web of Science ®Google Scholar
• Wlodarski MW, O’keefe C, Howe EC, Risitano AM, Rodriguez A, Warshawsky I, Loughran TP Jr, Maciejewski JP. Pathologic clonal cytotoxic T-cell responses: Nonrandom nature of the T-cell-receptor restriction in large granular lymphocyte leukemia. Blood 2005;106(8):2769–2780.
   PubMed Web of Science ®Google Scholar
• Beck RC, Wlodarski M, Gondek L, Theil KS, Tuthill RJ, Sobeck R, Bolwell B, Maciejewski JP. Efficient identification of T-cell clones associated with graft-versus-host disease in target tissue allows for subsequent detection in peripheral blood. Br J Haematol 2005;129(3):411–419.
   PubMed Web of Science ®Google Scholar
• van Dongen JJ, Langerak AW, Bruggemann M, Evans PA, Hummel M, Lavender FL, Delabesse E, Davi F, Schuuring E, Garcia-Sanz R, van Krieken JH, Droese J, Gonzalez D, Bastard C, White HE, Spaargaren M, Gonzalez M, Parreira A, Smith JL, Morgan GJ, Kneba M, Macintyre EA. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: Report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia 2003;17 (12): 2257— 2317 .
   PubMed Web of Science ®Google Scholar
• Kook H, Risitano AM, Zeng W, Wlodarski M, Lottemann C, Nakamura R, Barrett J, Young NS, Maciejewski JP. Changes in T-cell receptor VB repertoire in aplastic anemia: Effects of different immunosuppressive regimens. Blood 2002;99(10): 3668–3675.
   PubMed Web of Science ®Google Scholar
• Karadimitris A, Manavalan JS, Thaler HT, Notaro R, Araten DJ, Nafa K, Roberts IA, Weksler ME, Luzzatto L. Abnormal T-cell repertoire is consistent with immune process under-lying the pathogenesis of paroxysmal nocturnal hemoglobi-nuria. Blood 2000;96(7):2613–2620.
   PubMed Web of Science ®Google Scholar
• Hingorani R, Monteiro J, Furie R, Chartash E, Navarrete C, Pergolizzi R, Gregersen PK. Oligoclonality of V beta 3 TCR chains in the CD8+ T cell population of rheumatoid arthritis patients2 . J Immunol 1996;156 (2): 852–858.
   PubMed Web of Science ®Google Scholar
• Dupuy dA, Monier S, Jorgensen C, Gao Q, Travaglio-Encinoza A, Bologna C, Combe B, Sany J, Reme T. Increased percentage of CD3+, CD57+ lymphocytes in patients with rheumatoid arthritis. Correlation with duration of disease. Arthritis Rheum 1993;36(5):608–612.
   PubMed Web of Science ®Google Scholar
• Oksenberg JR, Panzara MA, Begovich AB, Mitchell D, Erlich HA, Murray RS, Shimonkevitz R, Sherritt M, Rothbard J, Bernard CC. Selection for T-cell receptor V beta-D beta-1 beta gene rearrangements with specificity for a myelin basic protein peptide in brain lesions of multiple sclerosis. Nature 1993;362(6415):68–70.
   PubMed Web of Science ®Google Scholar
• Ben-Nun A, Liblau RS, Cohen L, Lehmann D, Tournier-Lasserve E, Rosenzweig A, Zhang JW, Raus JC, Bach MA. Restricted T-cell receptor V beta gene usage by myelin basic protein-specific T-cell clones in multiple sclerosis: Predomi-nant genes vary in individuals. Proc Natl Acad Sci USA 1991;88(6):2466–2470.
   Google Scholar
• Beck RC, Stahl S, O’Keefe CL, Maciejewski JP, Theil KS, Hsi ED. Detection of mature T-cell leukemias by flow cytometry using anti-T-cell receptor V beta antibodies. Am J Chin Pathol 2003;120(5):785–794.
   PubMed Web of Science ®Google Scholar
• Schwab C, Willers J, Niederer E, Ludwig E, Kundig T, Grob P, Burg G, Dummer R. The use of anti-T-cell receptor-Vbeta antibodies for the estimation of treatment success and phenotypic characterization of clonal T-cell populations in cutaneous T-cell lymphomas. Br J Haematol 2002; 118(4):1019–1026.
   PubMed Web of Science ®Google Scholar
• Ponti R, Quaglino P, Novelli M, Fierro MT, Comessatti A, Peroni A, Bonello L, Bernengo MG. T-cell receptor gamma gene rearrangement by multiplex polymerase chain reac-tion/heteroduplex analysis in patients with cutaneous T-cell lymphoma (mycosis fungoides/Sezary syndrome) and benign inflammatory disease: Correlation with clinical, histological and immunophenotypical findings. Br J Dermatol 2005; 153(3):565–573.
   PubMed Web of Science ®Google Scholar
• Foroni L, Foldi J, Matutes E, Catovsky D, O’Connor NJ, Baer R, Forster A, Rabbitts TH, Luzzatto L. Alpha, beta and gamma T-cell receptor genes: Rearrangements correlate with haematological phenotype in T cell leukaemias. Br J Haematol 1987;67 (3) :307–318.
   PubMedGoogle Scholar
• Sutkowski N, Palkama T, Ciurli C, Sekaly RP, Thorley-Lawson DA, Huber BT. An Epstein-Barr virus-associated sup erantigen. J Exp Med 1996;184 (3) :971— 980.
   PubMed Web of Science ®Google Scholar
• Ishihara S, Okada S, Wakiguchi H, Kurashige T, Hirai K, Kawa-Ha K. Clonal lymphoproliferation following chronic active Epstein-Barr virus infection and hypersensitivity to mosquito bites. Am J Hematol 1997;54(4):276–281.
   PubMed Web of Science ®Google Scholar
• Tripp RA, Hamilton-Easton AM, Cardin RD, Nguyen P, Behm FG, Woodland DL, Doherty PC, Blackman MA. Pathogenesis of an infectious mononucleosis-like disease induced by a murine gamma-herpesvirus: Role for a viral superantigen? J Exp Med 1997;185 (9):1641–1650.
   PubMed Web of Science ®Google Scholar
• Labalette M, Salez F, Pruvot FR, Noel C, Dessaint JP. CD8 lymphocytosis in primary cytomegalovirus (CMV) infection of allograft recipients: Expansion of an uncommon CD8+. Clin Exp Immunol 1994;95(3):465–471.
   PubMed Web of Science ®Google Scholar
• Gorochov G, Debre P, Leblond V, Sadat-Sowti B, Sigaux F, Autran B. Oligoclonal expansion of CD8+ CD57+ T cells with restricted T-cell receptor beta chain variability after bone marrow transplantation. Blood 1994;83(2):587–595.
   PubMed Web of Science ®Google Scholar
• O’Keefe CL, Risitano AM, Maciejewski JP. Clinical implications of T cell receptor repertoire analysis after allogeneic stem cell transplantation. Hematology 2004;9 (3):189—198.
   PubMedGoogle Scholar
• Li H, Llera A, Malchiodi EL, Mariuzza RA. The structural basis of T cell activation by superantigens. Annu Rev Immunol 1999;17:435–466.
   PubMed Web of Science ®Google Scholar
• Petersson K, Pettersson H, Skartved NJ, Walse B, Forsberg G. Staphylococcal enterotoxin H induces V alpha-specific expansion of T cells. J Immunol 2003;170(8):4148–4154.
   PubMed Web of Science ®Google Scholar
• Matsutani T, Yoshioka T, Tsuruta Y, Shimamoto T, Ohyashiki JH, Suzuki R, Ohyashiki K. Determination of T-cell receptors of clonal CD8-positive T-cells in myelodys-plastic syndrome with erythroid hypoplasia. Leuk Res 2003;27 (4):305—312.
   PubMed Web of Science ®Google Scholar
• Trentin L, Imberti L, Zambello R, Sottini A, Raimondi R, Facco M, Cazzavillan S, Bonoldi E, Signorini S, Bacigalupo A, Semenzato G, Rodeghiero F, Primi D. Detection of identical T-cell clonotype expansions in both the donor and recipient after allogeneic bone marrow transplantation. Br J Haematol 1999;106(1):119–127.
   PubMed Web of Science ®Google Scholar